These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 24099237
21. Effect of cisapride on secondary peristalsis in patients with gastroesophageal reflux disease. Holloway RH, Penagini R, Schoeman MN, Dent J. Am J Gastroenterol; 1999 Mar; 94(3):799-803. PubMed ID: 10086669 [Abstract] [Full Text] [Related]
22. Gamma-aminobutyric acid receptor type B agonist baclofen inhibits acid-induced excitation of secondary peristalsis but not heartburn sensation. Wong MW, Hung JS, Liu TT, Yi CH, Lei WY, Chen CL. J Gastroenterol Hepatol; 2019 Feb; 34(2):370-375. PubMed ID: 30069912 [Abstract] [Full Text] [Related]
23. Effects of prucalopride on esophageal secondary peristalsis in humans. Yi CH, Lei WY, Hung JS, Liu TT, Chen CL. Clin Transl Gastroenterol; 2016 Nov 10; 7(11):e202. PubMed ID: 27831544 [Abstract] [Full Text] [Related]
24. Impact of ineffective esophageal motility on secondary peristalsis: Studies with high-resolution manometry. Lei WY, Liu TT, Wang JH, Yi CH, Hung JS, Wong MW, Gyawali CP, Chen CL. Neurogastroenterol Motil; 2021 Apr 10; 33(4):e14024. PubMed ID: 33174275 [Abstract] [Full Text] [Related]
25. Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Yarze JC, Varga J, Stampfl D, Castell DO, Jimenez SA. Am J Gastroenterol; 1993 Jun 10; 88(6):870-6. PubMed ID: 8503383 [Abstract] [Full Text] [Related]
26. Relevance of sleep disturbance to the integrity and characteristics of secondary peristalsis in patients with gastroesophageal reflux disease. Yi CH, Lei WY, Hung JS, Liu TT, Orr WC, Chen CL. Scand J Gastroenterol; 2017 Feb 10; 52(2):136-142. PubMed ID: 27608729 [Abstract] [Full Text] [Related]
29. [Long-term results of laparoscopic partial posterior fundoplication in patients with esophageal reflux and disorders of esophageal peristalsis]. Gadenstätter M, Klingler A, Klocker H, Wetscher GJ. Wien Klin Wochenschr; 2000 Jan 28; 112(2):70-4. PubMed ID: 10703154 [Abstract] [Full Text] [Related]
33. Ineffective motility is not a marker for gastroesophageal reflux disease. Vinjirayer E, Gonzalez B, Brensinger C, Bracy N, Obelmejias R, Katzka DA, Metz DC. Am J Gastroenterol; 2003 Apr 28; 98(4):771-6. PubMed ID: 12738454 [Abstract] [Full Text] [Related]
34. Effects of Acotiamide on the Esophageal Motility Function in Patients with Esophageal Motility Disorders: A Pilot Study. Muta K, Ihara E, Fukaura K, Tsuchida O, Ochiai T, Nakamura K. Digestion; 2016 Apr 28; 94(1):9-16. PubMed ID: 27326454 [Abstract] [Full Text] [Related]
35. Mosapride for gastroesophageal reflux disease in neurologically impaired patients. Komura M, Kanamori Y, Tanaka Y, Kodaka T, Sugiyama M, Terawaki K, Suzuki K, Iwanaka T. Pediatr Int; 2017 Mar 28; 59(3):347-351. PubMed ID: 27561215 [Abstract] [Full Text] [Related]
36. Effect of buspirone, a 5-HT1A receptor agonist, on esophageal motility in healthy volunteers. Di Stefano M, Papathanasopoulos A, Blondeau K, Vos R, Boecxstaens V, Farré R, Rommel N, Tack J. Dis Esophagus; 2012 Jul 28; 25(5):470-6. PubMed ID: 22050410 [Abstract] [Full Text] [Related]
37. Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro-esophageal reflux disease. Daum C, Sweis R, Kaufman E, Fuellemann A, Anggiansah A, Fried M, Fox M. Neurogastroenterol Motil; 2011 Jun 28; 23(6):517-e200. PubMed ID: 21272162 [Abstract] [Full Text] [Related]